BACKGROUND: Although Alzheimer's disease (AD) is a neurodegenerative disorder, there is growing interest in the influence of vascular factors on its incidence. METHODS: In a population-based longitudinal epidemiological study, we fit Cox proportional hazard models to examine the risk of incident dementia and AD associated with self-reported vascular disease. The population-attributable risk percent (percent of the incidence of dementia and AD in the population that would be eliminated if vascular disease was eliminated) was calculated using the adjusted hazard ratios (HR). RESULTS: Of 822 eligible participants, 94 individuals developed incident dementia, with 79 having AD (probable/possible AD) during the follow-up period of on average 8 years. Stroke/transient ischemic attack history was associated with incident dementia (HR=2.6) as well as AD (HR=2.4) among non-apolipoprotein E ɛ4 carriers. CONCLUSIONS: At the community level, the risk of dementia could be potentially reduced by 10.8% by eliminating overt cerebrovascular disease, and the risk of AD by 9.1% for non-apolipoprotein E ɛ4 carriers.
BACKGROUND: Although Alzheimer's disease (AD) is a neurodegenerative disorder, there is growing interest in the influence of vascular factors on its incidence. METHODS: In a population-based longitudinal epidemiological study, we fit Cox proportional hazard models to examine the risk of incident dementia and AD associated with self-reported vascular disease. The population-attributable risk percent (percent of the incidence of dementia and AD in the population that would be eliminated if vascular disease was eliminated) was calculated using the adjusted hazard ratios (HR). RESULTS: Of 822 eligible participants, 94 individuals developed incident dementia, with 79 having AD (probable/possible AD) during the follow-up period of on average 8 years. Stroke/transient ischemic attack history was associated with incident dementia (HR=2.6) as well as AD (HR=2.4) among non-apolipoprotein E ɛ4 carriers. CONCLUSIONS: At the community level, the risk of dementia could be potentially reduced by 10.8% by eliminating overt cerebrovascular disease, and the risk of AD by 9.1% for non-apolipoprotein E ɛ4 carriers.
Authors: Yuji Okura; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Richard J Rodeheffer Journal: J Clin Epidemiol Date: 2004-10 Impact factor: 6.437
Authors: Joshua A Sonnen; Eric B Larson; Paul K Crane; Sebastien Haneuse; Ge Li; Gerald D Schellenberg; Suzanne Craft; James B Leverenz; Thomas J Montine Journal: Ann Neurol Date: 2007-10 Impact factor: 10.422
Authors: Kathleen M Hayden; Peter P Zandi; Constantine G Lyketsos; Ara S Khachaturian; Lori A Bastian; Gene Charoonruk; JoAnn T Tschanz; Maria C Norton; Carl F Pieper; Ron G Munger; John C S Breitner; Kathleen A Welsh-Bohmer Journal: Alzheimer Dis Assoc Disord Date: 2006 Apr-Jun Impact factor: 2.703
Authors: Monica Garcia-Alloza; Julia Gregory; Kishore V Kuchibhotla; Sara Fine; Ying Wei; Cenk Ayata; Matthew P Frosch; Steven M Greenberg; Brian J Bacskai Journal: Brain Date: 2011-11-26 Impact factor: 13.501
Authors: Hiroko H Dodge; Jian Zhu; Randy Woltjer; Peter T Nelson; David A Bennett; Nigel J Cairns; David W Fardo; Jeffrey A Kaye; Deniz-Erten Lyons; Nora Mattek; Julie A Schneider; Lisa C Silbert; Chengjie Xiong; Lei Yu; Frederick A Schmitt; Richard J Kryscio; Erin L Abner Journal: Alzheimers Dement Date: 2016-12-23 Impact factor: 21.566
Authors: Elżbieta Kuźma; Ilianna Lourida; Sarah F Moore; Deborah A Levine; Obioha C Ukoumunne; David J Llewellyn Journal: Alzheimers Dement Date: 2018-08-31 Impact factor: 21.566
Authors: Laura B Zahodne; Nicole Schupf; Adam M Brickman; Richard Mayeux; Melanie M Wall; Yaakov Stern; Jennifer J Manly Journal: J Alzheimers Dis Date: 2016-04-12 Impact factor: 4.472
Authors: Renée F A G de Bruijn; Michiel J Bos; Marileen L P Portegies; Albert Hofman; Oscar H Franco; Peter J Koudstaal; M Arfan Ikram Journal: BMC Med Date: 2015-07-21 Impact factor: 8.775